MetrionAIIntelligence

Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Biohaven Ltd.

BHVN

HealthcareNYSEUS

$10.80

-$0.60 (-5.26%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

BHVN

1Y-0.6 (-5.26%)

Candles, volume, SMA 20, and SMA 50

O 11.33H 11.5L 10.61C 10.8Date Jun 5

BHVN

SMA 20 SMA 50 Vol 2.04MEEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$1.14B

Volume?2.03M

Avg Volume?2.31M

52w Range$7.48 - $18.566

Beta?3.31

Price Performance

+10.9%

$9.74 to $10.80

YTD

-4.3%

$11.29 to $10.80

-36.6%

$17.03 to $10.80

-52.1%

$22.57 to $10.80

N/A

history unavailable

10Y

N/A

history unavailable

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide

CEOVladimir Coric

IndustryBiotechnology

Employees256

IPO Date2022-09-23

CurrencyUSD

Websitewww.biohaven.com

Related stocks

Check out other names from the same Biotechnology industry as BHVN.

ABCL-

AbCellera Biologics Inc.

5.62USD

N/A

CLDX-

Celldex Therapeutics, Inc.

28.62USD

N/A

IMCR-

Immunocore Holdings plc

Intellia Therapeutics, Inc.

Sionna Therapeutics, Inc.

35.37USD

N/A

VERA-

Vera Therapeutics, Inc.

32.29USD

N/A

XERS-

Xeris Biopharma Holdings, Inc.

6.18USD

N/A

ZBIO-

Zenas BioPharma, Inc.

17.47USD

N/A